Literature DB >> 14604118

Determination of peptides and proteins in human urine with capillary electrophoresis-mass spectrometry, a suitable tool for the establishment of new diagnostic markers.

Stefan Wittke1, Danilo Fliser, Marion Haubitz, Sebastian Bartel, Ronald Krebs, Frank Hausadel, Meike Hillmann, Igor Golovko, Peer Koester, Hermann Haller, Thorsten Kaiser, Harald Mischak, Eva M Weissinger.   

Abstract

The on-line coupling of capillary electrophoresis (CE) with electrospray-time-of-flight mass spectrometry (MS) has been used to obtain patterns of peptides and proteins present in the urine of healthy human individuals. This led to the establishment of a "normal urine polypeptide pattern", consisting of 247 polypeptides, each of which was found in more than 50% of healthy individuals. Applying CE-MS to the analysis of urine of patients with kidney disease revealed differences in polypeptide pattern. Twenty-seven polypeptides were exclusively found in samples of patients. Another 13, present in controls, were missing. These data indicate that CE-MS can be applied as powerful tool in clinical diagnostics.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14604118     DOI: 10.1016/s0021-9673(03)00713-1

Source DB:  PubMed          Journal:  J Chromatogr A        ISSN: 0021-9673            Impact factor:   4.759


  31 in total

1.  Genetically modified donor leukocyte transfusion and graft-versus-leukemia effect after allogeneic stem cell transplantation.

Authors:  Sylvia Borchers; Elena Provasi; Anna Silvani; Marina Radrizzani; Claudia Benati; Elke Dammann; Annika Krons; Julia Kontsendorn; Joerg Schmidtke; Wolfgang Kuehnau; Nils von Neuhoff; Michael Stadler; Fabio Ciceri; Chiara Bonini; Arnold Ganser; Bernd Hertenstein; Eva M Weissinger
Journal:  Hum Gene Ther       Date:  2011-03-30       Impact factor: 5.695

Review 2.  The application of mass-spectrometry-based protein biomarker discovery to theragnostics.

Authors:  Jonathan M Street; James W Dear
Journal:  Br J Clin Pharmacol       Date:  2010-04       Impact factor: 4.335

3.  High-resolution proteome/peptidome analysis of peptides and low-molecular-weight proteins in urine.

Authors:  Harald Mischak; Bruce A Julian; Jan Novak
Journal:  Proteomics Clin Appl       Date:  2007-07-10       Impact factor: 3.494

4.  Identification and validation of urinary biomarkers for differential diagnosis and evaluation of therapeutic intervention in anti-neutrophil cytoplasmic antibody-associated vasculitis.

Authors:  Marion Haubitz; David M Good; Alexander Woywodt; Hermann Haller; Harald Rupprecht; Dan Theodorescu; Mohammed Dakna; Joshua J Coon; Harald Mischak
Journal:  Mol Cell Proteomics       Date:  2009-06-28       Impact factor: 5.911

5.  Urine proteome analysis reflects atherosclerotic disease in an ApoE-/- mouse model and allows the discovery of new candidate biomarkers in mouse and human atherosclerosis.

Authors:  Constantin von zur Muhlen; Eric Schiffer; Christine Sackmann; Petra Zürbig; Irene Neudorfer; Andreas Zirlik; Nay Htun; Alexander Iphöfer; Lothar Jänsch; Harald Mischak; Christoph Bode; Yung C Chen; Karlheinz Peter
Journal:  Mol Cell Proteomics       Date:  2012-02-27       Impact factor: 5.911

Review 6.  Current state of the art for enhancing urine biomarker discovery.

Authors:  Michael Harpole; Justin Davis; Virginia Espina
Journal:  Expert Rev Proteomics       Date:  2016-06       Impact factor: 3.940

7.  Proteomic candidate biomarkers of drug-induced nephrotoxicity in the rat.

Authors:  Rodney Rouse; Justyna Siwy; William Mullen; Harald Mischak; Jochen Metzger; Joseph Hanig
Journal:  PLoS One       Date:  2012-04-11       Impact factor: 3.240

Review 8.  Adapting mass spectrometry-based platforms for clinical proteomics applications: The capillary electrophoresis coupled mass spectrometry paradigm.

Authors:  Jochen Metzger; Peter B Luppa; David M Good; Harald Mischak
Journal:  Crit Rev Clin Lab Sci       Date:  2009       Impact factor: 6.250

Review 9.  Challenges of using mass spectrometry as a bladder cancer biomarker discovery platform.

Authors:  Eric Schiffer; Harald Mischak; Dan Theodorescu; Antonia Vlahou
Journal:  World J Urol       Date:  2008-01-04       Impact factor: 4.226

Review 10.  Urinary proteomic profiling for diagnostic bladder cancer biomarkers.

Authors:  Steve Goodison; Charles J Rosser; Virginia Urquidi
Journal:  Expert Rev Proteomics       Date:  2009-10       Impact factor: 3.940

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.